Oxford Technology Management Limited is a venture capital firm based in Oxford, United Kingdom, that specializes in investments in startup and early-stage technology-based businesses. Founded in 1983 by Lucius Cary, the firm targets unlisted companies, primarily in the science, technology, and engineering sectors, located within 60 miles of Oxford. The investment range typically spans from £100,000 to £2 million per transaction, with a strategy to allocate approximately half of the funds to early-stage companies that have achieved initial sales, while the remainder supports startup ventures at earlier stages. The firm's management team, composed of professionals with backgrounds in science and engineering, emphasizes a hands-on approach to understanding and managing their investments, leveraging their technical expertise to identify high-growth opportunities.
OxCan is a startup focused on early lung cancer detection using machine learning and liquid biopsy techniques. The company has developed an artificial intelligence-based healthcare platform that identifies cancer through targeted blood testing. This platform effectively detects cancer-related materials released into the bloodstream, allowing for cost-effective and routine analysis. It evaluates multidimensional liquid biopsy results, including DNA, proteins, epigenetic factors, as well as incorporating epidemiological data and patient medical histories. By providing healthcare providers with the tools for early cancer detection, OxCan aims to facilitate timely and potentially curative treatment options.
OxCan is a startup focused on early lung cancer detection using machine learning and liquid biopsy techniques. The company has developed an artificial intelligence-based healthcare platform that identifies cancer through targeted blood testing. This platform effectively detects cancer-related materials released into the bloodstream, allowing for cost-effective and routine analysis. It evaluates multidimensional liquid biopsy results, including DNA, proteins, epigenetic factors, as well as incorporating epidemiological data and patient medical histories. By providing healthcare providers with the tools for early cancer detection, OxCan aims to facilitate timely and potentially curative treatment options.
Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
Lightpoint Medical, Ltd., a medical device company, develops imaging technologies for cancer surgery. It develops Cerenkov Luminescence Imaging technology that detects cancer in real-time during surgery, and reduces the likelihood of cancer recurrence and the need for reoperation. Lightpoint Medical, Ltd. was formerly known as Artemis Diagnostics Ltd. and changed its name to Lightpoint Medical, Ltd. in January 2013. The company was founded in 2012 and is based in Rickmansworth, United Kingdom.
Gripable is develops simple digital therapy tools, combining them with mobile games, motivating physically impaired patients. GripAble began during our research with stroke patients struggling to use their hands for simple activities. Everyday tasks - getting dressed in the morning, holding a glass of water - are a huge frustration for them. This is the reality for over 500 million people around the world suffering with impaired arm mobility. These patients need, and want, more therapy. GripAble's first product is a highly sensitive, portable hand-grip that connects wirelessly with a mobile-based app, allowing patients to play our fun therapy games. It is designed for low-cost, easy-access assessment and therapy of hand and arm disability, providing increased engagement and allowing for self-training in hospitals and at home.
Oxwash operates as a laundry startup. Oxwash is re-engineering the laundry process from the ground up; our aim is for clinically-clean, net zero carbon emissions for the whole process, from collection, through washing and back to delivery.
curileum discovery Ltd develops therapeutic solutions to treat gastrointestinal diseases. The company was incorporated in 2013 and is based in London, United Kingdom.
Atelerix Limited provides storage and transportation of cells and tissues at room temperature. The company provides suspended cells, planted cells, and tissues. It also discovers and tests new drugs, develops cell therapies, and stores stem cells. The company was founded in 2006 and is based in Cambridge, United Kingdom.
Lightpoint Medical, Ltd., a medical device company, develops imaging technologies for cancer surgery. It develops Cerenkov Luminescence Imaging technology that detects cancer in real-time during surgery, and reduces the likelihood of cancer recurrence and the need for reoperation. Lightpoint Medical, Ltd. was formerly known as Artemis Diagnostics Ltd. and changed its name to Lightpoint Medical, Ltd. in January 2013. The company was founded in 2012 and is based in Rickmansworth, United Kingdom.
Atelerix Limited provides storage and transportation of cells and tissues at room temperature. The company provides suspended cells, planted cells, and tissues. It also discovers and tests new drugs, develops cell therapies, and stores stem cells. The company was founded in 2006 and is based in Cambridge, United Kingdom.
Bodle Technologies Limited provides advanced optoelectronic solutions for displays and smart windows. It offers zero-power reflective displays that are bi-stable reflective displays with ultra-high resolution; smart windows; and security coatings that change color under mechanical, optical or electrical probing techniques that result in unbreakable security features in currencies, ID cards, and official documentation. Its reflective displays are used in wearables, near-eye, and projection based displays. Bodle Technologies Limited was incorporated in 2015 and is headquartered in Begbroke, United Kingdom.
Gripable is develops simple digital therapy tools, combining them with mobile games, motivating physically impaired patients. GripAble began during our research with stroke patients struggling to use their hands for simple activities. Everyday tasks - getting dressed in the morning, holding a glass of water - are a huge frustration for them. This is the reality for over 500 million people around the world suffering with impaired arm mobility. These patients need, and want, more therapy. GripAble's first product is a highly sensitive, portable hand-grip that connects wirelessly with a mobile-based app, allowing patients to play our fun therapy games. It is designed for low-cost, easy-access assessment and therapy of hand and arm disability, providing increased engagement and allowing for self-training in hospitals and at home.
Ducentis is a pre-clinical stage company aiming to develop novel therapies for inflammation and autoimmune disease. Our target is the CD200/CD200R axis which imparts a deactivating signal to activated immune cells in both the innate and adaptive arms of the immune system. Potential therapeutic targets include transplant rejection and autoimmune and inflammatory disease affecting the lung, liver, kidney, eye, bone and cartilage.
Glide Pharmaceutical Technologies Limited is a clinical-stage development company based in Abingdon, United Kingdom, specializing in solid dose formulations of therapeutics and vaccines. The company has developed the Solid Dose Injector (SDI) system, aimed at enhancing patient compliance for those self-administering long-term therapies. Its product pipeline includes solid dose formulations for medications such as octreotide, teriparatide, and vaccines for anthrax and influenza. Additionally, Glide is working on a novel non-invasive diagnostic technology focusing on prostate cancer, which seeks to identify clinically significant disease through a biochemical marker. Founded in 2001, the company was previously known as Caretek Medical Ltd. before rebranding in 2006.
OxSonics Limited develops and commercializes SonoTran, an oncological drug delivery platform and injectable sono-sensitive particles. Its SonoTran drug delivery platform delivers drugs throughout tumours, including to the areas that lie furthest from blood vessels. The company also develops a pipeline of therapies for the treatment of solid tumours, mCRC, and pancreatic ductal adenocarcinoma. OxSonics Limited was founded in 2013 and is based in Oxford, United Kingdom.
Electrowinning Technologies has a method for controlling the very large currents which are used in metal winning operations. By controlling these currents, electrowinning plants would improve both the quality and the quantity of the metals produced and would also reduce energy consumption. There are also applications in electrorefining, the main copper refining method used in Europe.
curileum discovery Ltd develops therapeutic solutions to treat gastrointestinal diseases. The company was incorporated in 2013 and is based in London, United Kingdom.
Lupe Technology Limited is a consumer technology company based in the United Kingdom that specializes in the development and manufacture of cordless vacuum cleaners. Founded in 2014, the company focuses on enhancing suction power and endurance in its products through patented suction intensifier technology, which incorporates a cyclonic system and HEPA filtration for effective cleaning. Lupe Technology's vacuum cleaners feature a motorized agitator designed to tackle various surfaces, effectively removing hair and deep-seated dirt, while a removable battery pack allows for extended cleaning without interruptions. The company aims to reinvest profits to expand its market share in the floorcare sector and explore new product verticals, solidifying its presence within the industry.
Active Needle Technology is an early-stage medical device company focused on enhancing treatment pathways through innovative image-guided interventional radiology. The company has developed a proprietary platform that utilizes ultrasonic technology to improve the accuracy of imaging and needle placement in vivo. This advancement significantly enhances the safety and efficiency of needle-based procedures, benefiting both clinicians and patients. By providing a reliable solution for medical professionals, Active Needle aims to transform how interventional radiology is performed, ultimately delivering improved healthcare outcomes.
Molecular Warehouse Ltd. develops proteins for diagnostics and therapeutics. The company was incorporated in 2015 and is based in Twickenham, United Kingdom.
Ducentis is a pre-clinical stage company aiming to develop novel therapies for inflammation and autoimmune disease. Our target is the CD200/CD200R axis which imparts a deactivating signal to activated immune cells in both the innate and adaptive arms of the immune system. Potential therapeutic targets include transplant rejection and autoimmune and inflammatory disease affecting the lung, liver, kidney, eye, bone and cartilage.
Orbit Discovery Ltd. is a peptide display technology company based in Oxford, United Kingdom, founded in 2015. The company specializes in identifying peptide drugs aimed at treating chronic diseases by leveraging its innovative in vitro display technology. This technology utilizes small beads to connect randomized peptide sequences with their corresponding DNA, facilitating the screening of peptides for various disease types. Orbit Discovery focuses on developing a screening platform that identifies potential peptide drug candidates for both internal drug discovery programs and collaborative research initiatives. The company’s platform offers a means to discover and optimize novel, biologically relevant peptides, capitalizing on the unique properties of peptides that combine the specificity and efficacy of larger biologic molecules with the advantages of smaller molecules, such as reduced dosing and simpler manufacturing processes. This approach aims to enhance the discovery and development of peptide-based therapeutics.
Azellon Limited develops and commercializes a platform technology using mesenchymal stem cells infused into a biological scaffold for tissue repair. The company offers Cell Bandage, a tissue repair technology that is used in the repair of tears of the avascular (white) zone knee meniscus. Its technology combines one’s own bone marrow stem cells with a special membrane that helps to deliver the cells into the injured site. Azellon Limited was incorporated in 2007 and is based in London, United Kingdom.
Lightpoint Medical, Ltd., a medical device company, develops imaging technologies for cancer surgery. It develops Cerenkov Luminescence Imaging technology that detects cancer in real-time during surgery, and reduces the likelihood of cancer recurrence and the need for reoperation. Lightpoint Medical, Ltd. was formerly known as Artemis Diagnostics Ltd. and changed its name to Lightpoint Medical, Ltd. in January 2013. The company was founded in 2012 and is based in Rickmansworth, United Kingdom.
Sime Diagnostics Ltd is a clinical AI platform company specializing in neonatal healthcare. Founded in 2014 and headquartered in London, the company develops advanced software that utilizes artificial intelligence to generate data-driven insights for medical professionals. Its primary offering is the Neonatal Lung Maturity Test (LMT), which predicts Respiratory Distress Syndrome (RDS) in premature infants, aiming to reduce morbidity and mortality rates in this vulnerable population. Sime Diagnostics leverages its patented technologies to detect diseases in real-time, facilitating early intervention for high-risk patients. Additionally, the company's AI platform curates and analyzes unique datasets that can aid in the discovery of new disease biomarkers and support third-party partners across various medical fields. With operations also in Copenhagen and Shanghai, Sime Diagnostics combines expertise in medicine and data science to address urgent healthcare needs in neonatal intensive care.
It specialises in location based marketing solutions to help brands improve customer relationships and loyalty. Founded in 2013 by Thomas Young, the company has grown strength to strength working with some of the biggest brands to name.
Designer Carbon Materials Ltd is developing advanced nanomaterials for a range of applications, including energy harvesting, bio-sensing and quantum nanoelectronics. We are producing designer endohedral fullerene molecules with tailored electronic properties. Designer Carbon Materials Ltd is a spin-out company from the University of Oxford. It is based on research led by Dr Kyriakos Porfyrakis and his academic group of 9 researchers. Dr Porfyrakis has been developing methods for the synthesis and chemical functionalization of endohedral fullerenes for over 12 years. Designer Carbon Materials Ltd has licensed the intellectual property portfolio developed by Dr Porfyrakis and his group.
Abgentis Limited develops IV/oral antibacterial products to treat acute and chronic, life-threatening and drug-resistant infections. It focuses on re-engineering Abgentis, a previously marketed antibacterial by deploying a unique insight into the structure-activity relationships, microbiology, pharmacology, and efficacy of antibacterial DNA supercoiling inhibitors. The company was incorporated in 2012 and is based in Abingdon, United Kingdom.
Run3D Limited operates clinics specializing in musculoskeletal assessments aimed at addressing persistent injuries. Founded in 2012 and based in Witney, United Kingdom, the company offers services such as three-dimensional gait analysis for various needs, including running injuries, biomechanical issues, and footwear selection for new runners and triathletes. Run3D employs a state-of-the-art 3D motion capture system alongside a comprehensive biomechanical database to provide precise evaluations of biomechanics, muscular strength, flexibility, and alignment. The insights gained from these assessments help clinicians develop personalized rehabilitation programs with evidence-based solutions. With clinics located in Surrey, Essex, Basingstoke, London, Oxford, and Dublin, Run3D collaborates with leading institutions like the Running Injury Clinic at the University of Calgary to advance its approach to musculoskeletal overuse injuries.
Organic LED (OLED) displays represent the most promising new display technology to have emerged in the past 20 years; more efficient, powerful and cleaner than the prevailing LED, LCD and Plasma standards.
OLEDs offer enhanced performance in terms of response time, viewing angle, contrast ratio and flexibility, and environmental advantages, with low power consumption, fewer materials, longer lifetime and no requirement for a backlight to drive them.
Power OLEDs is at the forefront of developing world-class, high performance hole transporters, electron transporters, electron injectors, host and emitters for selected global manufacturers.
Led by a strong team with over 60 years combined experience in the OLED space, the company holds a wide IP estate and a strong pipeline of new materials.
Combat Medical are a Spanish company that have developed a new treatment for bladder cancer, and are planning to start the business in the UK.
The current treatment for bladder cancer involves surgery to cut the tumours out. This treatment results in a 78% recurrence rate, and so calls for more and more surgery. Combat Medical's treatment involves heating up chemotherapy chemicals and circulating them around the bladder. It currently boasts a recurrence rate of less than 20% - a marked improvement. It also offers great cost savings, as there is less of a chance of having to perform additional surgeries.
It specialises in location based marketing solutions to help brands improve customer relationships and loyalty. Founded in 2013 by Thomas Young, the company has grown strength to strength working with some of the biggest brands to name.
Metal Powder & Process
Seed Round in 2013
Metal Powders & Process is seeking to build an atomiser that will produce metal powders is high volumes, with no impurities. The hope is that this will allow more industries to begin using metal powders to craft their components. Currently, contaminants in metal powders cause weak points in components, which are negligible for most purposes, but unusable under high stress in environments such as Aerospace.
Lightpoint Medical, Ltd., a medical device company, develops imaging technologies for cancer surgery. It develops Cerenkov Luminescence Imaging technology that detects cancer in real-time during surgery, and reduces the likelihood of cancer recurrence and the need for reoperation. Lightpoint Medical, Ltd. was formerly known as Artemis Diagnostics Ltd. and changed its name to Lightpoint Medical, Ltd. in January 2013. The company was founded in 2012 and is based in Rickmansworth, United Kingdom.
MicroVisk Limited, founded in 2004 and based in Oxford, United Kingdom, specializes in medical technology. The company has developed CoagMax, a point-of-care monitor that enables home testing for prothrombin time (PT) and international normalized ratio (INR) blood tests. In addition, MicroVisk is engaged in the creation of Micro Electro Mechanical Sensors, targeting the international medical market. By focusing on innovative solutions for blood testing and medical device technologies, MicroVisk aims to enhance patient care and facilitate easier access to vital health information.
IBEXIS TECHNOLOGIES is a leading provider of innovative sensory networking, remote data acquisition, monitoring and control products, systems and solutions. We have clients in a variety of industries including the Environmental, Building and Construction, Energy and Industrial sectors and they utilise our expertise to: Increase Customer Satisfaction Levels Significantly Reduce Operational Costs Improve Health and Safety in the Work Place Lower their Organisation’s Carbon Footprint Execute their CSR Strategies Ensure Regulatory Compliance Capable of supporting a variety of lead industry specific protocols, our solutions are used to remotely monitor and control industrial equipment (e.g. HMI’s and PLCs), sensors, probes as well as management and supervisory systems. Having an open systems approach enables our solutions to not only readily integrate into existing customer environments, but also extends (and often enhances) the capability of on-site systems to remote users who can securely access, control and monitor such systems using their laptop or smart device and also receive any relevant warnings and alerts. Our product and services portfolio is comprised of our IM SERIES Hardware and Systems product range, Enterprise Monitoring Software Suite, Managed Services, System Integration Services and Hardware and Software Product Development expertise.
It specialises in location based marketing solutions to help brands improve customer relationships and loyalty. Founded in 2013 by Thomas Young, the company has grown strength to strength working with some of the biggest brands to name.
Combat Medical are a Spanish company that have developed a new treatment for bladder cancer, and are planning to start the business in the UK.
The current treatment for bladder cancer involves surgery to cut the tumours out. This treatment results in a 78% recurrence rate, and so calls for more and more surgery. Combat Medical's treatment involves heating up chemotherapy chemicals and circulating them around the bladder. It currently boasts a recurrence rate of less than 20% - a marked improvement. It also offers great cost savings, as there is less of a chance of having to perform additional surgeries.
BioMoti Limited develops cancer therapeutics. It seeks to transform the treatment of cancer by targeted delivery of therapeutics to the intracellular space of cancer cells. The company’s Oncojans are a new class of therapeutic microparticles that can target and gain entry to the interior of cancer cells where they slowly release drugs at the point of need whilst sparing healthy tissue. Its products also include MOTI1001, an Oncojans based ovarian cancer candidate. The company was incorporated in 2009 and is based in London, United Kingdom.
Run3D Limited operates clinics specializing in musculoskeletal assessments aimed at addressing persistent injuries. Founded in 2012 and based in Witney, United Kingdom, the company offers services such as three-dimensional gait analysis for various needs, including running injuries, biomechanical issues, and footwear selection for new runners and triathletes. Run3D employs a state-of-the-art 3D motion capture system alongside a comprehensive biomechanical database to provide precise evaluations of biomechanics, muscular strength, flexibility, and alignment. The insights gained from these assessments help clinicians develop personalized rehabilitation programs with evidence-based solutions. With clinics located in Surrey, Essex, Basingstoke, London, Oxford, and Dublin, Run3D collaborates with leading institutions like the Running Injury Clinic at the University of Calgary to advance its approach to musculoskeletal overuse injuries.
Acunu Analytics offers a platform for low-latency, continuous analytics on big data; powering dashboards and embedded applications to monitor and control environments in manufacturing, telecommunications, media, financial services and other industries where high-velocity data must be analysed in real time. The Cassandra NoSQL database is at the core of the Acunu offering and Acunu is a very engaged Cassandra contributor donating many of its innovations back to the community. Acunu was founded in 2009 and is backed by some of Europe’s top VC funds. Started by a unique mix of researchers and engineers from Cambridge and Oxford Universities, Acunu has offices in London (near Old Street, London’s “Silicon Roundabout”) and California.
Azellon Limited develops and commercializes a platform technology using mesenchymal stem cells infused into a biological scaffold for tissue repair. The company offers Cell Bandage, a tissue repair technology that is used in the repair of tears of the avascular (white) zone knee meniscus. Its technology combines one’s own bone marrow stem cells with a special membrane that helps to deliver the cells into the injured site. Azellon Limited was incorporated in 2007 and is based in London, United Kingdom.
Select Technology is a design and engineering company, provides software solutions for the copier and multi-function device industry. It offers PaperCut MF, a print, copy, fax, and scan management solution; KPAX Manage, a print fleet management solution for resellers; Presto, which enables users to publish existing Windows print queues to iOS device; EveryonePrint, a mobile print solution; Drivve Image, a scanning software; and selectSCAN, a scanning and capture solution for employees.
Orthogem Limited is a company based in Nottingham, United Kingdom, that specializes in the development and manufacture of synthetic bone grafts. Since its founding in 2001, Orthogem has leveraged its patented Tripore technology platform to create a diverse range of synthetic bone graft products suitable for various clinical applications, including spinal surgery and oral craniofacial procedures. The company's product lineup features TriPore Granules, TriPore MPA, and TriPore Blocks, which are designed to meet the needs of medical professionals in the field of orthopedic and reconstructive surgery.
MicroVisk Limited, founded in 2004 and based in Oxford, United Kingdom, specializes in medical technology. The company has developed CoagMax, a point-of-care monitor that enables home testing for prothrombin time (PT) and international normalized ratio (INR) blood tests. In addition, MicroVisk is engaged in the creation of Micro Electro Mechanical Sensors, targeting the international medical market. By focusing on innovative solutions for blood testing and medical device technologies, MicroVisk aims to enhance patient care and facilitate easier access to vital health information.
Crysalin Limited, founded in June 2007 and based in London, specializes in the research and development of crysalin lattice technology, which is derived from patented work initiated in 2002 at the Oxford University Laboratory of Molecular Biophysics. The company's core product, crysalins, is a protein-based nanotechnology that significantly enhances the determination of protein structures, particularly for challenging targets such as membrane proteins and soluble proteins with flexible regions. Crysalins enable the resolution of three-dimensional molecular structures using X-ray and electron microscopy techniques, where traditional methods have struggled. In addition to protein structure determination, crysalins hold potential applications in biosensor development and optoelectronics, showcasing the versatility and innovative capacity of the technology.
Acunu Analytics offers a platform for low-latency, continuous analytics on big data; powering dashboards and embedded applications to monitor and control environments in manufacturing, telecommunications, media, financial services and other industries where high-velocity data must be analysed in real time. The Cassandra NoSQL database is at the core of the Acunu offering and Acunu is a very engaged Cassandra contributor donating many of its innovations back to the community. Acunu was founded in 2009 and is backed by some of Europe’s top VC funds. Started by a unique mix of researchers and engineers from Cambridge and Oxford Universities, Acunu has offices in London (near Old Street, London’s “Silicon Roundabout”) and California.
MicroVisk Limited, founded in 2004 and based in Oxford, United Kingdom, specializes in medical technology. The company has developed CoagMax, a point-of-care monitor that enables home testing for prothrombin time (PT) and international normalized ratio (INR) blood tests. In addition, MicroVisk is engaged in the creation of Micro Electro Mechanical Sensors, targeting the international medical market. By focusing on innovative solutions for blood testing and medical device technologies, MicroVisk aims to enhance patient care and facilitate easier access to vital health information.
LabMinds Limited specializes in automating solution preparation in liquid-handling laboratories globally, focusing on the pharmaceutical and life sciences sectors. Founded in 2009 and headquartered in Oxford, United Kingdom, with an additional office in Somerville, Massachusetts, the company offers The Revo solution preparation system, which enhances the drug development process. This system integrates advanced AI software with robotics to minimize manual handling, thereby reducing risks and waste associated with solution preparation. LabMinds' cloud-based platform allows for remote access and facilitates data collection on chemical interactions, providing labs with valuable insights. By improving security and efficiency in laboratory processes, LabMinds aims to support scientists and businesses in optimizing their operations and accelerating the journey of new therapies to market.
Glide Pharmaceutical Technologies Limited is a clinical-stage development company based in Abingdon, United Kingdom, specializing in solid dose formulations of therapeutics and vaccines. The company has developed the Solid Dose Injector (SDI) system, aimed at enhancing patient compliance for those self-administering long-term therapies. Its product pipeline includes solid dose formulations for medications such as octreotide, teriparatide, and vaccines for anthrax and influenza. Additionally, Glide is working on a novel non-invasive diagnostic technology focusing on prostate cancer, which seeks to identify clinically significant disease through a biochemical marker. Founded in 2001, the company was previously known as Caretek Medical Ltd. before rebranding in 2006.
Base4 is focused on the innovation and development of state-of-the-art technologies for single-molecule analysis. We are developing cutting-edge, high-value technologies with demonstrable technical and commercial feasibility while building a valuable portfolio of IP and know-how.
MicroVisk Limited, founded in 2004 and based in Oxford, United Kingdom, specializes in medical technology. The company has developed CoagMax, a point-of-care monitor that enables home testing for prothrombin time (PT) and international normalized ratio (INR) blood tests. In addition, MicroVisk is engaged in the creation of Micro Electro Mechanical Sensors, targeting the international medical market. By focusing on innovative solutions for blood testing and medical device technologies, MicroVisk aims to enhance patient care and facilitate easier access to vital health information.
Diamond Microwave Devices Ltd. engages in the development of semiconductor devices based on CVD diamond. Its devices are used in civil and defense systems for microwave power amplifier and transmitter applications. The company was founded in 2006 and is based in Leeds, the United Kingdom. Diamond Microwave Devices Ltd. operates as a subsidiary of Element Six (Pty) Ltd.
Acunu Analytics offers a platform for low-latency, continuous analytics on big data; powering dashboards and embedded applications to monitor and control environments in manufacturing, telecommunications, media, financial services and other industries where high-velocity data must be analysed in real time. The Cassandra NoSQL database is at the core of the Acunu offering and Acunu is a very engaged Cassandra contributor donating many of its innovations back to the community. Acunu was founded in 2009 and is backed by some of Europe’s top VC funds. Started by a unique mix of researchers and engineers from Cambridge and Oxford Universities, Acunu has offices in London (near Old Street, London’s “Silicon Roundabout”) and California.
Azellon Limited develops and commercializes a platform technology using mesenchymal stem cells infused into a biological scaffold for tissue repair. The company offers Cell Bandage, a tissue repair technology that is used in the repair of tears of the avascular (white) zone knee meniscus. Its technology combines one’s own bone marrow stem cells with a special membrane that helps to deliver the cells into the injured site. Azellon Limited was incorporated in 2007 and is based in London, United Kingdom.
OrganOx Limited develops device known as Metra to store livers outside the body at normal body temperature. It engages in the research and study for test and transplant of livers. The company’s products are used to preserve the livers before transplantations. OrganOx Limited was incorporated in 2008 and is based in the Oxford, United Kingdom.
Mirriad’s award-winning solution unleashes new revenue for content producers and distributors by creating new advertising inventory in content. Our patented, AI and computer vision technology dynamically inserts products and innovative signage formats after content is produced. Mirriad’s market-first solution seamlessly integrates with existing subscription and advertising models, and dramatically improves the viewer experience by limiting commercial interruptions.
Mirriad currently operates in the US, Europe and China.
Agilent Raman Spectroscopy’s proprietary technologies use novel variants of Raman spectroscopy. Their instruments can rapidly and accurately identify materials hidden inside objects or through opaque barriers such as plastic, coloured glass, paper and skin, or can measure the concentrations of materials in mixtures, with a high degree of accuracy. Agilent Raman Spectroscopy is formerly known as Cobalt Light Systems and is part of Agilent.
Glide Pharmaceutical Technologies Limited is a clinical-stage development company based in Abingdon, United Kingdom, specializing in solid dose formulations of therapeutics and vaccines. The company has developed the Solid Dose Injector (SDI) system, aimed at enhancing patient compliance for those self-administering long-term therapies. Its product pipeline includes solid dose formulations for medications such as octreotide, teriparatide, and vaccines for anthrax and influenza. Additionally, Glide is working on a novel non-invasive diagnostic technology focusing on prostate cancer, which seeks to identify clinically significant disease through a biochemical marker. Founded in 2001, the company was previously known as Caretek Medical Ltd. before rebranding in 2006.
Leveraging the extensive knowledge of GSK's Biotransformation and Natural Products scientific team, Novacta Biosystems Ltd was founded in 2003. In the following 5 years, Novacta successfully adopted a dual business model, whereby it developed a biocatalysis and microbial pathway engineering service business, that supported its efforts to build an infectious disease therapeutic pipeline.
Arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform. Arecor is leveraging this platform to develop a portfolio of proprietary products enabling improved treatments for diabetes care via the innovative reformulation of approved proteins and peptides.
In addition to its internal product portfolio, Arecor partners with leading pharmaceutical and biotech companies to deliver superior reformulations of their proprietary products, which would otherwise not be possible using conventional formulation science.
Historic Futures Ltd specializes in supply-chain traceability solutions, providing advanced technologies and consulting expertise to help brands and retailers visualize and manage their supply chains. Founded in 2003 and based in Witney, United Kingdom, the company offers the String3 platform, which allows organizations to share comprehensive product and process information, identify risk areas, and communicate best practices. Their software facilitates the collection of reliable, up-to-date data, enabling clients to understand the history of their products, reduce risks, and create sustainable value. By connecting organizations with their supply chains, Historic Futures enhances the ability to send and receive traceability information, detailed risk reports, and file attachments through a unified platform.
Pharma Engineering Ltd
Venture Round in 2007
Pharma Engineering has developed and patented a gentle method to remove tablets and capsules from blister packs without damaging them. The pharmaceutical industry is large and manufactures billions of blister-packaged tablets. It is common for 2-6% of this manufactured product to be stopped for quality reasons relating to the packaging. Recovering these tablets so that they can be re-packaged can yield easy savings.
Oxtox is developing Drugsensorâ„¢, a device that uses novel and cost-effective technology to rapidly detect whether a person is currently 'under the influence' of specific drugs, all with a minimum of inconvenience.
Incentec Ltd
Venture Round in 2006
Incentec Ltd has been developing a predictive diagnostic for pre-eclampsia, a poorly defined condition affecting approximately 6% of first pregnancies. The causes of pre-eclampsia are unknown, although a failure in placental development is thought to be a factor. There is no diagnostic test currently in use and at the moment, at-risk patients (or suspected cases of pre-eclampsia) are monitored and treated on the basis of observable and developing clinical symptoms.
Imagineer Systems Limited offers research, development, and marketing services for visual effects solutions in film, video, and broadcast post production. Its products include monet, a tracking and compositing toolset and mokey, a toolset for removing wires, rigs, logos, scratches, and hairs for commercial, film, and corporate video post production. Additionally, the company provides mocha, a 2D tracking and rotoscoping tool that generates position, scale, rotation, shear, and perspective matched tracks for special effects in film and video production. Imagineer Systems also offers virtual product placement, lens distortion correction, noise reduction, grain management, and keying tools. Imagineer Systems Limited was founded in 2000 and is based in Guildford, United Kingdom.
Dexela develops a 3-D breast imaging technology for the early detection of breast cancer. It offers DexTop Digital Mammography Workstation, a screening workstation that ensures screening workflow and performance; and Dexela 3D reconstruction engine that is offered to OEM partners as a software module with licensing terms. The company provides flat panel CMOS X-ray detectors that are used in various medical applications, including mammography and tomosynthesis, breast CT, dental CBCT, fluoroscopy, cardiology and angiographic imaging, and bone densitometry, as well as in scientific instrumentation and non-destructive testing applications. It also offers consulting services in the areas of digital tomosynthesis, mammography acquisition geometry, and optimal reconstruction of 3D data; and design and implementation resources for hardware and software engineering projects. Dexela Limited was incorporated in 2003 and is based in London, the United Kingdom. It has an X-ray research and development facility in Sudbury, Massachusetts.
Usentric develops online proxy solution for brands in the retail, financial services and telecommunication industries. The company's products and services include secure payment online solutions, email protection, and secure ID. It is based in Sutton, U.K.
Glide Pharmaceutical Technologies Limited is a clinical-stage development company based in Abingdon, United Kingdom, specializing in solid dose formulations of therapeutics and vaccines. The company has developed the Solid Dose Injector (SDI) system, aimed at enhancing patient compliance for those self-administering long-term therapies. Its product pipeline includes solid dose formulations for medications such as octreotide, teriparatide, and vaccines for anthrax and influenza. Additionally, Glide is working on a novel non-invasive diagnostic technology focusing on prostate cancer, which seeks to identify clinically significant disease through a biochemical marker. Founded in 2001, the company was previously known as Caretek Medical Ltd. before rebranding in 2006.
Inspiration Matters has developed a software and hardware system to drive high quality displays such as those used in car dealerships, estate agents and banks.
Wright Fenn provides medicine pills are manufactured and packaged in blister packs. For many patients, such as those in residential or care homes, hospitals or other institutions, these pills are repackaged by the pharmacy into dosage specific monthly packs to save nursing time and reduce dosage errors. Pharmaceutical licenses typically specify the form of the packaging and so it is expensive for the manufacturers to make and package pills in bulk form for pharmacies to repackage them into dosage specific packs. During 2003, pharmacists in the UK alone deblistered and repackaged approximately 70 million packs of pills ' mostly by hand. The number of patients requiring these patient specific packs is increasing each year at about 10-15%.
Dynamic Extractions was set up to commercialise the unique and world leading Hydrodynamic Counter Current Chromatography (HdCCC) technology.
Kinomi
Seed Round in 2005
Kinomi provides a better way of automatically archiving and indexing email, both by subject matter, sender and receiver groups, and by reading content, which then enables people and organisations to retrieve relevant emails much more easily, if ever they are needed at some point in the future.
BioAnaLab Ltd.
Venture Round in 2005
BioAnaLab Ltd. is a services provider that specializes in the analysis of biologic drugs and vaccines. BioAnaLab was spun out of the University of Oxford in 2002 to meet the unique requirements of the biopharmaceutical industry. The Company helps its customers better understand the safety and efficacy of biologic drugs and vaccines by providing a broad range of services to assist with evaluating and advancing these therapeutics from the drug development pipeline to the market
Water Innovate focuses on bridging the gap between research and industry innovation in the water and environmental sectors. The company specializes in the development and commercialization of advanced water and wastewater treatment technologies. By evaluating new technologies and investing resources in their development, Water Innovate effectively identifies routes to market. Their portfolio includes a variety of cutting-edge products designed by leading experts in the field, aimed at addressing the challenges faced by the water industry. These technologies are systematically transferred from research laboratories to the marketplace, facilitating practical solutions for the international water and environmental sectors.
Scancell Holdings plc is focused on the discovery and development of innovative vaccines aimed at treating various cancers and infectious diseases. The company's primary product candidates include SCIB1, currently in phase II clinical trials for metastatic melanoma, and SCIB2, which is undergoing phase I/II combination trials for non-small cell lung cancer. Additionally, Modi-1 is in phase I/II clinical trials targeting head and neck, triple negative breast, ovarian, and renal cancers, while Modi-2 is in pre-clinical trials for multiple solid tumors. Scancell utilizes its ImmunoBody® and Moditope™ technology platforms to develop these therapeutic vaccines. The company has established collaborations with BioNTech for T-cell receptor based therapeutics, ISA Pharmaceuticals B.V. for utilizing AMPLIVANT adjuvant technology, and several academic institutions for COVID-19 vaccine development. Founded in 1997 and based in Oxford, United Kingdom, Scancell is dedicated to advancing cancer immunotherapy.
Inscentinel
Venture Round in 2005
Inscentinel uses the exquisitely sensitive olfactory sense of bees to detect minute concentrations of volatile compounds such as explosives, drugs, or odours that indicate disease. The bees are held in a harness and can then be trained to recognize particular scents, in much the same way that sniffer dogs can be trained. In the presence of the odour for which they have been trained, the bees have a proboscis extension reflex, and this is then picked up by a camera and its associated software that then sends a signal to an operator or simply logs the data. A US patent has been granted and other patent applications are proceeding.
Caretek Medical
Venture Round in 2005
Caretek Medical has developed a needle-free injection technology. The system comprises a hand-held spring-powered reusable actuator plus a single-use disposable cassette which houses a splinter of drug in solid form. In use, the cassette is engaged with the actuator and then pressed against the skin. This pressure further charges an internal spring and, at the critical point, the internal components are brought into alignment, releasing the spring which then causes the drug splinter to be pushed to a controlled and repeatable depth within the skin. The basic idea is covered by a number of patent applications which have recently started to grant.
Diamond Hard Surfaces has developed a process to create amorphous diamond-like carbon coatings at lower temperatures (<50oC) and in thicker layers (up to 20 microns) than existing processes. Diamond Hard Surfaces coatings have the extreme surface characteristics of diamond such as low coefficient of friction and excellent wear properties. In addition, carbon is inert to almost everything and so is an excellent barrier against chemical corrosion.
Leveraging the extensive knowledge of GSK's Biotransformation and Natural Products scientific team, Novacta Biosystems Ltd was founded in 2003. In the following 5 years, Novacta successfully adopted a dual business model, whereby it developed a biocatalysis and microbial pathway engineering service business, that supported its efforts to build an infectious disease therapeutic pipeline.
Scancell Holdings plc is focused on the discovery and development of innovative vaccines aimed at treating various cancers and infectious diseases. The company's primary product candidates include SCIB1, currently in phase II clinical trials for metastatic melanoma, and SCIB2, which is undergoing phase I/II combination trials for non-small cell lung cancer. Additionally, Modi-1 is in phase I/II clinical trials targeting head and neck, triple negative breast, ovarian, and renal cancers, while Modi-2 is in pre-clinical trials for multiple solid tumors. Scancell utilizes its ImmunoBody® and Moditope™ technology platforms to develop these therapeutic vaccines. The company has established collaborations with BioNTech for T-cell receptor based therapeutics, ISA Pharmaceuticals B.V. for utilizing AMPLIVANT adjuvant technology, and several academic institutions for COVID-19 vaccine development. Founded in 1997 and based in Oxford, United Kingdom, Scancell is dedicated to advancing cancer immunotherapy.
Hardide plc manufactures and sells tungsten carbide-based coatings for external and internal surfaces in the United Kingdom, Europe, North America, and internationally. The company offers custom coatings; and base material coatings for various steel and alloy materials, as well as coatings for seals. It provides its products for use in various industries and applications, including oil and gas, aerospace, valves, pumps, industrial diamond, power generation, motorsport, material processing, industrial tooling, and blades. The company was founded in 2000 and is headquartered in Bicester, the United Kingdom.
Invro Limited operates as an electronic engineering company. The company focuses on the management of electrical energy by electronic means. It offers single earpiece radios, radio receiver sets, and FM radios. The company also provides high voltage power supplies for scientific and industrial applications; and instrumentation for power electronics applications. Invro Limited was incorporated in 2003 and is based in Bristol, the United Kingdom.
Caretek Medical
Venture Round in 2003
Caretek Medical has developed a needle-free injection technology. The system comprises a hand-held spring-powered reusable actuator plus a single-use disposable cassette which houses a splinter of drug in solid form. In use, the cassette is engaged with the actuator and then pressed against the skin. This pressure further charges an internal spring and, at the critical point, the internal components are brought into alignment, releasing the spring which then causes the drug splinter to be pushed to a controlled and repeatable depth within the skin. The basic idea is covered by a number of patent applications which have recently started to grant.
Telegesis Ltd. specializes in the design, manufacture, and supply of ZigBee modules utilizing the Ember Silicon Labs platform. These modules are embedded in various products across consumer, commercial, industrial, and government applications globally. The company's product offerings include ZigBee radio modules, development kits, USB sticks, home automation evaluation kits, and smart energy compliant displays. Telegesis also provides ZigBee gateways and consumer access devices for applications in commercial lighting, health monitoring, and industrial sensor networks, among others. Additionally, the company offers external antennas and off-the-shelf firmware. Telegesis serves diverse sectors including smart energy, building control, renewable energy, and the Internet of Things, distributing its products through representatives and online channels primarily in the United States. Established in 1998 and based in High Wycombe, United Kingdom, Telegesis operates as a subsidiary of Silicon Laboratories Inc. and maintains strategic partnerships with various companies in the industry.
Ciphergrid
Seed Round in 2003
Ciphergrid Ltd (previously Cipherware Ltd) has developed what it believes is a unique data access technology that, in its simplest form, enables enterprise applications (e.g. ERP, CRM, or stand alone applications such as MS Excel) to perform transactions with multiple, disparate, remote databases across the Internet in the same way (speed, functionality, security) as if the databases were local. Ciphergrid's uniqueness lies in the fact that it offers a reliably high transactional speed, that it is a 'plug & play' solution and that it offers significantly lower total cost of ownership than any alternative. Its built-in data encryption and security control mechanisms allow the use of the Internet instead of expensive, non scaleable, leased lines.
Reviver Technologies
Seed Round in 2003
ReviveR Technologies Limited, (formerly known as PC Help Centre) is a UK based research and development company, which specialises in designing intelligent remote diagnostic tools for use within mission-critical PCs, servers and manufacturing control equipment. Today, ReviveR Technologies offer affordable diagnostic tools that provide advanced, yet simplified secure remote access, monitor and control management for mission-critical equipment 24/7/365. The essence of the technology is that a board or chip resides in a PC or server and reports back over the internet on the detailed status of the PC. If a fault develops, the fault is reported. If it cant be corrected remotely as is often possible with software faults, then an engineer is able to arrive with the necessary hardware module so that the fault may be fixed at a single visit.
Commerce Decisions delivers proven software – AWARD, best practice knowledge and expert services to assist sourcing projects through-life; from preparation, qualification, evaluation, negotiation to continuous supplier performance review and contract compliance. AWARD software provides a central web-based information and process & infrastructure enabling project teams to collaboratively make major contract decisions and monitor subsequent performance. It is proven to significantly increase contract value and reduce risk and used in projects totalling over £150 billion to date. AWARD is available in the UK via a number of routes, including CCS frameworks. Commerce Decisions customers include the Department for Transport, DWP, Defra, Transport for London, NHS, the UK Olympic Delivery Authority, the British Broadcasting Corporation, defence contractors and the UK and Finnish MOD.
Inscentinel
Seed Round in 2003
Inscentinel uses the exquisitely sensitive olfactory sense of bees to detect minute concentrations of volatile compounds such as explosives, drugs, or odours that indicate disease. The bees are held in a harness and can then be trained to recognize particular scents, in much the same way that sniffer dogs can be trained. In the presence of the odour for which they have been trained, the bees have a proboscis extension reflex, and this is then picked up by a camera and its associated software that then sends a signal to an operator or simply logs the data. A US patent has been granted and other patent applications are proceeding.
Im-Pak Technologies
Seed Round in 2003
The Im-Pak technology has now been successfully demonstrated on three moulds, a water cup, a paint-can, and on a mould for a pre-form for PET bottles. In January 2006, Im-Pak agreed heads of terms by which a public company will take a licence for the Im-Pak process for use in certain market areas. At the time of writing, the deal has reached draft legal contract stage, and it is expected that the deal will be concluded in May. Im-Pak will receive both regular monthly payments, as advance royalties, plus two lump-sum payments, and will share in royalties generated by licensing the technology round the world. Im-Pak will continue to develop the technology for other applications.
Concurrent Thinking Limited specializes in the design and implementation of large-scale computing infrastructures and software tailored for high-performance computing. Based in Warwick, United Kingdom, the company offers a range of data center infrastructure management solutions, including concurrentCOMMAND, which integrates with facilities management systems to optimize energy efficiency, and concurrentCONTROL, a platform for monitoring power, environmental conditions, servers, and operating systems within data centers. Additionally, Concurrent Thinking provides support and maintenance services to its clients, which include IT, environmental, and financial sectors, as well as facilities management. Established in 2009 and formerly known as Retromaze Limited, the company rebranded in June 2010 to reflect its focus on innovative approaches to system management and scalable computing solutions.
Provider of a technology platform intended to be used for customer data integration. The company's technology platform offers Customer Relationship Management (CRM) and enterprise integration services, enabling businesses to avail code-free integration and migration tools to make fully informed business decisions.
Metal Nanopowders Ltd. is a manufacturer and supplier of high-quality metal powders, specializing in nanopowders such as aluminum, iron, copper, nickel, magnesium, titanium, and titanium nitride. Established in 2002, the company is based in Birmingham, United Kingdom, and originated as a spinout from the University of Birmingham. Metal Nanopowders Ltd. focuses on the production and development of nanopowders in varying quantities, utilizing a patented process that ensures exceptional purity and physical properties. The company's commitment to innovation and quality positions it as a key player in the field of advanced materials.
Ixaris Systems Ltd. operates a payments platform. The company offers virtual prepaid Visa card and EntroPay services; and a suite of corporate prepaid payments applications. It serves financial services, travel, travel assistance, and other industries in the United Kingdom and internationally. Ixaris Systems Ltd. was formerly known as Global e-Mobile Ltd. and changed its name to Ixaris Systems Ltd. in December 2002. The company was founded in 2000 and is based in London, United Kingdom.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.